Share-based Payment Arrangement, Expense of ABEONA THERAPEUTICS INC. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ABEONA THERAPEUTICS INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • ABEONA THERAPEUTICS INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,689,000, a 49% increase year-over-year.
  • ABEONA THERAPEUTICS INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $10,175,000, a 64% increase year-over-year.
  • ABEONA THERAPEUTICS INC. annual Share-based Payment Arrangement, Expense for 2024 was $6,628,000, a 39% increase from 2023.
  • ABEONA THERAPEUTICS INC. annual Share-based Payment Arrangement, Expense for 2023 was $4,768,000, a 56% increase from 2022.
  • ABEONA THERAPEUTICS INC. annual Share-based Payment Arrangement, Expense for 2022 was $3,051,000, a 66% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ABEONA THERAPEUTICS INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,175,000 $2,689,000 +$885,000 +49% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $9,290,000 $2,830,000 +$1,507,000 +114% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $7,783,000 $2,701,000 +$1,155,000 +75% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $6,628,000 $1,955,000 +$441,000 +29% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $6,187,000 $1,804,000 +$247,000 +16% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $5,940,000 $1,323,000 +$396,000 +43% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $5,544,000 $1,546,000 +$776,000 +101% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $4,768,000 $1,514,000 +$681,000 +82% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $4,087,000 $1,557,000 +$925,000 +146% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $3,162,000 $927,000 +$203,000 +28% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $2,959,000 $770,000 -$92,000 -11% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $3,051,000 $833,000 -$1,168,000 -58% 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $4,219,000 $632,000 -$1,905,000 -75% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $6,124,000 $724,000 -$1,704,000 -70% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $7,828,000 $862,000 -$1,088,000 -56% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $8,916,000 $2,001,000 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $2,537,000 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $2,428,000 +$850,000 +54% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,950,000 +$694,000 +55% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q2 2020 $6,391,000 $1,578,000 -$100,000 -6% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $6,491,000 $1,256,000 -$847,000 -40% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $7,338,000 $1,731,000 01 Oct 2019 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 $1,826,000 -$673,000 -27% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,678,000 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $2,103,000 +$203,000 +11% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q3 2018 $2,499,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q1 2018 $1,900,000 +$408,000 +27% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $1,492,000 -$100,000 -6.3% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $5,736,000 $1,592,000 +$1,368,000 +611% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $4,368,000 $1,788,000 +$1,642,000 +1125% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $2,726,000 $1,452,000 +$1,280,000 +744% 01 Jul 2015 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 $1,446,000 $904,000 +$712,000 +371% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 $734,000 $224,000 -$571,000 -72% 01 Jan 2015 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 $1,305,000 $146,000 +$61,000 +72% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $1,244,000 $172,000 +$146,000 +562% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 $1,098,000 $192,000 -$59,000 -24% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $1,157,000 $795,000 +$718,000 +932% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 $439,000 $85,000 +$2,000 +2.4% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 $437,000 $26,000 -$59,000 -69% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $496,000 $251,000 +$143,000 +132% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $353,000 $77,000 -$37,000 -32% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $390,000 $83,000 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q3 2012 $85,000 -$259,000 -75% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $108,000 -$134,000 -55% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 $114,000 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q3 2011 $344,000 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $242,000 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2

ABEONA THERAPEUTICS INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,628,000 +$1,860,000 +39% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $4,768,000 +$1,717,000 +56% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $3,051,000 -$5,865,000 -66% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
2021 $8,916,000 +$3,063,000 +52% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $5,853,000 -$1,485,000 -20% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $7,338,000 -$840,000 -10% 01 Jan 2019 31 Dec 2019 10-K 24 Mar 2021 2020 FY
2018 $8,178,000 +$3,534,000 +76% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $4,644,000 -$185,000 -3.8% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $4,829,000 +$461,000 +11% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $4,368,000 +$3,063,000 +235% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $1,305,000 +$866,000 +197% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $439,000 +$49,000 +13% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $390,000 -$676,000 -63% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
2011 $1,066,000 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.